Journals / Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi / 2025 / Volume: 12 Issue: 3

Evaluation of Risk Factors for Prolonged QTc Interval in Patients Undergoing Dialysis

Diyaliz Hastalarında Uzamış QTc Süresi İle İlişkili Risk Faktörlerinin Araştırılması

Veysel Baran Tomar(GAZİ ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-2123-5207
Taha Enes Cetin(GAZİ ÜNİVERSİTESİ)0000-0003-2125-5881
Rojhat Erdem(GAZİ ÜNİVERSİTESİ)0009-0006-9874-3559
Deniz Aksöz(GAZİ ÜNİVERSİTESİ)0009-0006-2256-0641
Umut Can Karaaslan(MUGLA SITKI KOCMAN UNIVERSITY)0009-0004-8029-2644
Saliha Yildirim(Sincan Eğitim ve Araştırma Hastanesi)0000-0002-2693-1167
Asil Demirezen(GAZİ ÜNİVERSİTESİ)0009-0004-4449-8266
Özant Helvacı(GAZİ ÜNİVERSİTESİ)0000-0002-1382-2439
Ulver Derıcı(GAZİ ÜNİVERSİTESİ)0000-0002-9741-6779
Pages
—
Publication Date
2025-12-29
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings suggest that QTc interval prolongation in dialysis patients is primarily related to age and structural cardiac abnormalities, and may serve as a valuable parameter in the assessment of cardiac risk in this population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The present study aimed to evaluate the relationship between corrected QT (QTc) interval and demographic, clinical, and laboratory variables in patients undergoing hemodialysis or peritoneal dialysis due to end-stage renal disease, and to identify independent risk factors associated with QTc interval prolongation.
📊
Key Findings & Data:This retrospective and cross-sectional study included 147 adult patients who had been receiving regular dialysis treatment for at least six months.
💡
Conclusion & Impact:These findings suggest that QTc interval prolongation in dialysis patients is primarily related to age and structural cardiac abnormalities, and may serve as a valuable parameter in the assessment of cardiac risk in this population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Corrected QT Interval · End-Stage Renal Disease · Hemodialysis

Abstract

The present study aimed to evaluate the relationship between corrected QT (QTc) interval and demographic, clinical, and laboratory variables in patients undergoing hemodialysis or peritoneal dialysis due to end-stage renal disease, and to identify independent risk factors associated with QTc interval prolongation. This retrospective and cross-sectional study included 147 adult patients who had been receiving regular dialysis treatment for at least six months. Based on electrocardiographic findings, patients were categorized into two groups according to their QTc interval status; normal and prolonged. Variables such as age, presence of heart failure, ejection fraction, medication use, and laboratory parameters were compared between the groups. Patients with prolonged QTc intervals were older, had lower ejection fraction, and a higher prevalence of heart failure. Beta-blocker use was also more frequent in this group. In multivariate logistic regression analysis, only advanced age was found to be independently associated with QTc interval prolongation. No significant association was observed between QTc interval and electrolyte levels, triglyceride-glucose index, or dialysis modality. These findings suggest that QTc interval prolongation in dialysis patients is primarily related to age and structural cardiac abnormalities, and may serve as a valuable parameter in the assessment of cardiac risk in this population.

Özet

Çalışmamız, son dönem böbrek yetmezliği nedeniyle hemodiyaliz veya periton diyalizi tedavisi alan hastalarda, düzeltilmiş QT aralığı ile demografik, klinik ve laboratuvar değişkenler arasındaki ilişkiyi değerlendirmek ve QTc aralığı uzaması ile ilişkili bağımsız risk faktörlerini belirlemek amacıyla yapılmıştır. Retrospektif ve kesitsel olarak tasarlanan araştırmaya, en az altı aydır düzenli diyaliz tedavisi alan 147 yetişkin hasta dahil edilmiştir. Elektrokardiyografi bulgularına göre hastalar, normal ve uzamış QTc aralığına sahip olanlar şeklinde iki gruba ayrılmış; yaş, kalp yetersizliği varlığı, ejeksiyon fraksiyonu, kullanılan ilaçlar ve laboratuvar değerleri gibi değişkenler açısından karşılaştırılmıştır. Uzamış QTc aralığı olan hastalar daha ileri yaşta olup, daha düşük ejeksiyon fraksiyonuna ve daha yüksek oranda kalp yetersizliğine sahipti. Ayrıca bu grupta beta bloker kullanım sıklığı da daha fazlaydı. Çok değişkenli lojistik regresyon analizinde yalnızca ileri yaş, QTc aralığı uzaması ile bağımsız olarak ilişkili bulunmuştur. Elektrolit düzeyleri, trigliserid-glukoz indeksi ve diyaliz yöntemi ile QTc aralığı arasında anlamlı bir ilişki saptanmamıştır. Bu bulgular, diyaliz tedavisi alan hastalarda QTc aralığı uzamasının özellikle yaş ve yapısal kalp bozukluklarıyla ilişkili olabileceğini ve kardiyak riskin öngörülmesinde dikkate alınması gereken bir parametre olduğunu göstermektedir.

🔖

Cite This Article

Tomar, V. B., Cetin, T. E., Malkoç, N. A., Erdem, R., Aksöz, D., Karaaslan, U. C., Yildirim, S., Demirezen, A., Akçay, Ö. F., Helvacı, Ö., Derıcı, U. (2025). Evaluation of Risk Factors for Prolonged QTc Interval in Patients Undergoing Dialysis. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, Volume: 12 Issue: 3. https://doi.org/10.47572/muskutd.1744914

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (21)

  1. Cu Goldenberg I, Moss AJ, Zareba W. QT interval: How to measure it and what is “normal.” J Cardiovasc Electrophysiol. 2006;17(3):333–6.
  2. Schwartz PJ, Woosley RL. Predicting the unpredictable: Drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol. 2016;67(13):1639–50.
  3. Kim ED, Watt J, Tereshchenko LG, et al. Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol. 2019;20(1):133.
  4. Klivinyi C, Bornemann-Cimenti H. Pain medication and long QT syndrome. Korean J Pain 2018;31:3-9.
  5. Solak Y, Yilmaz MI, Saglam M, et al. Cardiac repolarization parameters in dialysis patients. Clin Nephrol. 2012;77(5):378–85.
  6. Kalkan S, Erken E, Ozturk İ, et al. Hemodiyaliz hastalarında kardiyak repolarizasyon belirteçlerinin klinik bulgularla ilişkisi. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi. 2022;9(1):22–27.
  7. Koçyiğit İ, Demir G. Hemodiyaliz hastalarında QTc süresi ile serum elektrolit düzeyleri arasındaki ilişkinin değerlendirilmesi. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi. 2021;8(3):172–7.
  8. Cui C, Liu L, Zhang T, et al. Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2023;22(1):325.
  9. Park B, Lee YJ. Metabolic syndrome and its components as risk factors for prolonged corrected QT interval in apparently healthy Korean men and women. J Clin Lipidol. 2018 Sep-Oct;12(5):1298-1304.
  10. Rabkin SW, Cheng XJ, Thompson DJ. Detailed analysis of the impact of age on the QT interval. J Geriatr Cardiol. 2016 Sep;13(9):740-748.
  11. Matsumoto Y, Mori Y, Kageyama S, et al. Changes in QTc interval in long-term hemodialysis patients. PLoS One. 2019;14(1):e0209297.
  12. Al-Khatib SM, LaPointe NMA, Kramer JM, et al. What clinicians should know about the QT interval. JAMA. 2003;289(16):2120–7.
  13. Davey PP, Barlow C, Hart G. Prolongation of the QT interval in heart failure occurs at low but not at high heart rates. Clin Sci (Lond). 2000 May;98(5):603-10.
  14. Genovesi S, Dossi C, Valsecchi MG, et al. Electrolyte concentration during hemodialysis and QT interval prolongation. J Nephrol. 2003;16(4):566–570.
  15. Pun PH, Lehrich RW, Honeycutt EF, et al. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int. 2011;79(2):218–27.
  16. Miró Ò, Aguiló O, Trullàs JC, et al. QT interval and short-term outcome in acute heart failure. Clin Res Cardiol. 2023;112(12):1754–65.
  17. Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis. 2001;38(6):1343–1350.
  18. Di Iorio B, Bellasi A. QT interval in CKD and haemodialysis patients. Clin Kidney J. 2013 Apr;6(2):137-43.
  19. Sánchez‐Íñigo L, Navarro‐González D, Fernández‐Montero A, et al. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–97.
  20. Unger G, Benozzi SF, Perruzza F, et al. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr. 2014;61(10):533–40.
  21. Cetin Sanlialp S, Nar G, Gunver MG. Elevated triglyceride glucose index is related to the presence of heart failure. J Ist Faculty Med 2022;85(1):51-8.